3/25
01:01 pm
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $74.00 price target on the stock.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $74.00 price target on the stock.
3/21
08:34 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at Jefferies Financial Group Inc. from $41.00 to $72.00. They now have a "buy" rating on the stock.
Medium
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at Jefferies Financial Group Inc. from $41.00 to $72.00. They now have a "buy" rating on the stock.
3/20
08:08 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock.
Medium
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $48.00 price target on the stock.
3/19
07:00 am
trml
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Medium
Report
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
2/27
07:30 am
trml
Tourmaline Bio to Present at Upcoming Investor Conferences
Low
Report
Tourmaline Bio to Present at Upcoming Investor Conferences